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Abstract
Objective: To determine the frequency of and the factors related to delayed diagnosis of sarcoidosis in Brazil. 
Methods: We evaluated patients with a biopsy-proven diagnosis of sarcoidosis, using a questionnaire that 
addressed the following: time since symptom onset and since the first medical visit; and the number and specialty 
of the physicians visited. We divided the patients by the timeliness of the diagnosis—timely (< 6 months) and 
delayed (≥ 6 months)—comparing the two groups in terms of systemic and pulmonary symptoms; extrathoracic 
involvement; spirometric data; radiological staging; level of education; income; and tuberculosis (diagnosis 
and treatment). Results: We evaluated 100 patients. The median number of physicians consulted was 3 (range, 
1-14). In 11 cases, sarcoidosis was diagnosed at the first visit. In 54, the first physician seen was a general 
practitioner. The diagnosis of sarcoidosis was timely in 41 patients and delayed in 59. The groups did not differ 
in terms of gender; race; type of health insurance; level of education; income; respiratory/systemic symptoms; 
extrathoracic involvement; and radiological staging. In the delayed diagnosis group, FVC was lower (80.3 ± 
20.4% vs. 90.5 ± 17.1%; p = 0.010), as was FEV1 (77.3 ± 19.9% vs. 86.4 ± 19.5%; p = 0.024), misdiagnosis 
with and treatment for tuberculosis (≥ 3 months) also being more common (24% vs. 7%, p = 0.032, and 20% 
vs. 0%; p = 0.002, respectively). Conclusions: The diagnosis of sarcoidosis is often delayed, even when the 
imaging is suggestive of sarcoidosis. Delayed diagnosis is associated with impaired lung function at the time of 
diagnosis. Many sarcoidosis patients are misdiagnosed with and treated for tuberculosis. 
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Resumo
Objetivo: Avaliar a frequência do diagnóstico tardio de sarcoidose no Brasil e os fatores relacionados a esse 
atraso. Métodos: Avaliamos pacientes com diagnóstico de sarcoidose confirmado por biópsia utilizando um 
questionário que abordava o tempo entre o início dos sintomas e a data da primeira consulta médica; e o 
número e especialidades dos médicos consultados. Sintomas sistêmicos e pulmonares, envolvimento extratorácico, 
dados espirométricos, estadiamento radiológico, escolaridade, renda individual e diagnóstico/tratamento de 
tuberculose foram comparados entre os pacientes com diagnóstico precoce (< 6 meses até o diagnóstico) e 
tardio (≥ 6 meses). Resultados: Foram incluídos 100 pacientes. A mediana do número de médicos consultados 
foi 3 (variação: 1-14). O diagnóstico de sarcoidose foi feito na primeira consulta em 11 casos. Um clínico geral 
foi inicialmente consultado em 54 casos. O diagnóstico de sarcoidose foi precoce em 41 casos e tardio em 59. 
Não houve diferença entre os grupos no tocante ao gênero, raça, tipo de seguro saúde, escolaridade, renda, 
sintomas sistêmicos e respiratórios, envolvimento extratorácico e estadiamento radiológico. Os pacientes com 
diagnóstico tardio apresentavam menor CVF (80,3 ± 20,4% vs. 90,5 ± 17,1%; p = 0,010) e VEF1 (77,3 ± 19,9% 
vs. 86,4 ± 19,5%; p = 0,024), além de mais frequentemente receberem diagnóstico de tuberculose (24% vs. 7%; 
p = 0,032) e tratamento para tuberculose (≥ 3 meses; 20% vs. 0%; p = 0,002). Conclusões: O diagnóstico de 
sarcoidose é tardio em muitos casos, mesmo quando há achados de imagem sugestivos. O diagnóstico tardio 
está associado a menor função pulmonar na época do diagnóstico. Vários pacientes com sarcoidose recebem 
diagnóstico e tratamento de tuberculose. 
Descritores: Sarcoidose; Sarcoidose pulmonar/diagnóstico; Tuberculose.
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those treated at any of the following facilities in 
the city of São Paulo, Brazil: the Hospital São 
Paulo Outpatient Clinic for Interstitial Diseases 
(n = 68); the São Paulo Hospital for State Civil 
Servants (n = 22); and a private clinic owned by 
one of the authors of the present study (n = 10). 
A standardized questionnaire was administered 
at diagnosis or retrospectively, up to one year 
after diagnosis. Data were collected between 
June of 2007 and May of 2011. 
We excluded patients who were unable to 
remember the time of symptom onset or the number 
of physicians consulted, as well as those who were 
unable to perform acceptable spirometric maneuvers. 
In the initial evaluation, patients underwent 
history taking, detailed physical examination, 
and ancillary tests to determine whether there 
was multiple organ involvement by sarcoidosis.(1) 
Chest X-rays and CT scans taken closest to the 
date of biopsy were reviewed. The chest X-ray 
findings were classified in accordance with the 
criteria proposed by Scadding(8): stage 0, no 
thoracic involvement; stage I, hilar adenopathy 
alone; stage II, hilar enlargement with interstitial 
lung disease; stage III, interstitial lung disease 
alone; and stage IV, pulmonary fibrosis. 
All spirometric tests met the acceptability 
and reproducibility criteria proposed by the 
Brazilian Thoracic Association, and the results 
were expressed as predicted values for the Brazilian 
population.(9,10) Abnormal patterns were classified 
as obstructive (reduced FEV1/FVC ratio with 
normal FVC), restrictive (reduced FVC and FEV1 
with normal FEV1/FVC ratio), or mixed (reduced 
FVC and FEV1/FVC ratio). Dyspnea was assessed 
by the baseline dyspnea index.(11) Dyspnea was 
considered severe when the score was ≤ 6. 
Patients answered questions regarding the date 
of symptom onset, the date of the first medical visit, 
the number of physicians visited (and their specialty), 
and the specialty of the physician who made the 
diagnosis of sarcoidosis. Physicians were classified 
as general practitioners or generalists (including 
emergency room physicians), pulmonologists, 
dermatologists, ophthalmologists, or others. 
The clinical presentation of sarcoidosis 
was classified as asymptomatic (abnormal 
radiological findings without symptoms), 
pulmonary symptoms, cutaneous symptoms, 
ocular symptoms, systemic symptoms (fever, 
weight loss, and night sweats), or others. 
Introduction
A diagnosis of sarcoidosis is established 
when clinical and radiological findings are 
associated with the histological presence of 
granulomas and causes other than sarcoidosis 
have been excluded.(1,2) The diagnosis of sarcoidosis 
is often delayed for various reasons. The disease 
is uncommon and can affect any organ system. 
The clinical presentation of sarcoidosis can be 
typical(1,3,4) or atypical. 
In countries in which the number of cases of 
tuberculosis is high, such as Brazil, a diagnosis 
of tuberculosis is always considered in patients 
in whom a biopsy shows granulomas, and such 
patients often receive treatment for tuberculosis 
(even without bacteriological confirmation). Similarly 
to tuberculosis, sarcoidosis predominantly affects 
the upper lobes, and parenchymal fibrosis can cause 
architectural distortion, hilar retraction, and upper 
lobe volume loss.(5) Patients with sarcoidosis can 
present with systemic symptoms, such as fever, 
weight loss, and night sweats, which can lead 
physicians to misdiagnose such patients as having 
tuberculosis.(6) Sarcoidosis is asymptomatic in many 
cases. In symptomatic patients, the symptoms are 
generally nonspecific. Finally, economic barriers and 
difficult access to specialists can affect the time 
to diagnosis. In a study conducted in the United 
States and involving 189 patients, the diagnosis 
was delayed (> 6 months after symptom onset) 
in 31%.(7) The presence of pulmonary symptoms 
and radiological findings indicative of advanced 
disease were associated with a longer time to 
diagnosis. In contrast, the presence of skin lesions 
resulted in earlier diagnosis. 
The objective of the present study was to 
determine the frequency of and the factors related 
to delayed diagnosis of sarcoidosis in patients 
seeking treatment at specialized centers in Brazil. 
Methods
The study protocol was approved by the 
Research Ethics Committee of the Federal University 
of São Paulo, located in the city of São Paulo, 
Brazil. All patients gave written informed consent. 
Clinical and biopsy findings were consistent with 
sarcoidosis in all of the patients included in the 
present study. Other conditions were excluded on 
the basis of the results of ancillary tests, including 
special stains for mycobacteria and fungi on 
biopsy slides. Patients were recruited from among 
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in which granulomatous lesions were found. The 
diagnosis was based on incidental chest X-ray 
findings in 13% of the cases. Systemic symptoms 
were common: 46% of the patients reported weight 
loss; 35% reported night sweats; and 20% reported 
fever. Increased dyspnea was reported by 19%. 
Mean FVC and FEV1 values (as assessed by 
spirometry) were close to the lower limit of the 
reference range, and the mean FEV1/FVC ratio 
was normal. Spirometric values were within the 
reference range in 44 cases; 29 cases were classified 
as restrictive, 19 were classified as obstructive, 
and 8 were classified as mixed. 
In 49 cases, the diagnosis of sarcoidosis 
was based on transbronchial biopsy findings. 
Skin lesions and extrathoracic adenopathy were 
common, and one third of the cases were diagnosed 
on the basis of biopsy findings in those sites. 
The median number of physicians consulted was 
3 (range, 1-14). The first physician consulted was a 
general practitioner in 54 cases; a pulmonologist, 
in 13; a dermatologist, in 7; and other specialists, 
in 24. Sarcoidosis was diagnosed at the first visit 
in only 11 patients; 6 patients were diagnosed by a 
dermatologist, 3 were diagnosed a pulmonologist, 
Patients were classified as Black or White on 
the basis of their skin color. The level of education 
was classified as illiterate, elementary school, high 
school, or college. The monthly individual income 
was quantified by the number of times the average 
minimum wage at the time of the study: 1-3 (600-
1,800 Brazilian reals); 4-10; and > 10. Health 
insurance was classified as public or private. 
The diagnosis of sarcoidosis was classified as 
timely (< 6 months) or delayed (≥ 6 months) on 
the basis of the time elapsed between the first 
medical visit and the date of the visit in which 
the diagnosis of sarcoidosis was established. 
Variables with normal distribution were 
expressed as mean and standard deviation, 
and those with non-normal distribution were 
expressed as median and range. The chi-square 
test was used in order to compare the timely 
diagnosis and delayed diagnosis groups regarding 
categorical variables. Regarding variables with 
normal distribution, the two groups of patients 
were compared by the Student’s t-test. Regarding 
those with non-normal distribution, they were 
compared by the Kruskal-Wallis test or the Mann-
Whitney test. Correlations of FVC% with the time 
elapsed between symptom onset and diagnosis 
were determined by Spearman’s test. 
A preliminary analysis of sarcoidosis patients 
showed that approximately half had had a delayed 
diagnosis. Considering a difference of 20% in the 
frequency of findings between the two groups 
relevant, with values of α = 0.05 and power 
(1 − β) of 0.80, we found that a sample of 97 
cases was required.(12) Statistical analysis was 
performed with the Statistical Package for the 
Social Sciences, version 17.0 for Windows (SPSS 
Inc., Chicago, IL, USA). Statistical significance 
was set at p < 0.05 (two-tailed). 
Results
One hundred patients were included in the 
present study. The overall findings are shown in 
Table 1. White females constituted the majority 
of the sample. The mean age was 48 years, being 
higher for females than for males (50.1 ± 12.1 
years vs. 43.9 ± 11.4 years; t = 2.57; p = 0.012). 
Of the sample as a whole, 79% had public 
health insurance, 52% had finished college, 
and 60% had a monthly income of less than 
2,000 Brazilian reals. 
Table 2 shows the clinical, functional, and 
radiological findings, as well as the biopsy sites 
Variable Result
Age, yearsb 47.6 ± 12.1
Gender
Male 40
Female 60
Race
White 79
Black 21
Health insurance
Private 21
Public 79
Level of education
Illiterate 8
Elementary school 40
High school 33
University 19
Monthly income, no. of times the 
national minimum wagec
≤ 1 6
1-3 54
4-10 29
> 10 11
Table 1 - General characteristics of 100 patients 
with sarcoidosis.a
aValues expressed as n of patients, except where otherwise 
indicated. bValue expressed as mean ± SD. cNational minimum 
wage, in Brazilian reals (R$) = R$ 600.00.
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patients consulted with a physician within 6 
months after the onset of symptoms. 
Fifty-nine patients (59%) were diagnosed 
late (≥ 6 months after the first visit), whereas 
the remaining 41 (41%) were diagnosed timely. 
The time elapsed from the onset of symptoms 
to the first visit was similar between the two 
groups. The median duration of symptoms was 
1 month in the group of patients with timely 
diagnosis group and 2 months in the delayed 
diagnosis group (z = 0.24; p = 0.81). 
The time elapsed from the onset of symptoms 
to the first visit and from the onset of symptoms 
to the diagnosis of sarcoidosis did not differ 
between the genders, races, or types of health 
insurance, or among levels of education or incomes 
(data not shown). 
Table 3 shows a comparison between the 
timely and delayed diagnosis groups in terms of 
clinical, functional, and imaging findings. Those 
in the delayed diagnosis group had a higher mean 
age, a lower FVC, and a lower FEV1, as well as 
having been more commonly misdiagnosed with 
and treated for tuberculosis. Of the 59 patients 
in the delayed diagnosis group, 24 (40.7%) had 
restrictive lung disease, when compared with 6 
(14.6%) of the 41 patients in the timely diagnosis 
group (p = 0.005). 
There were no differences between the patients 
in the timely diagnosis group and those in the 
delayed diagnosis group regarding systemic 
symptoms, respiratory symptoms, or the frequency 
of extrathoracic involvement. In addition, there 
were no differences between the two groups of 
patients regarding radiological staging. In 97 
patients, CT scans were available for review. After 
the application of the Scadding classification 
system to the CT scans, there were changes in 
the radiological staging of 50 patients, 36 of 
whom moved to a higher stage. Only 1 of the 
8 cases classified as stage 0 on the basis of 
routine chest X-ray findings remained at that 
stage after HRCT staging. 
In 21 cases, the disease stage changed from 
I, II, or III to IV. There were no differences 
between the patients in the timely diagnosis 
group and those in the delayed diagnosis group 
regarding CT staging (Table 3). When the disease 
stages were grouped into 0/I/II vs. III/IV and 
compared regarding diagnosis (timely or delayed), 
no differences were observed. 
and 2 were diagnosed by a general practitioner. In 
26 cases, five or more physicians were consulted 
before the correct diagnosis was made. 
All patients visited one of our facilities, 
meaning that, by the end of the study, all 
patients had consulted with a pulmonologist. 
Before that, 68 patients had consulted with 
90 pulmonologists, the diagnosis having been 
established in 28 patients (31%). 
The median time elapsed from the onset of 
symptoms or from an abnormal radiological 
finding to the first visit was 1 month; the median 
time elapsed from the first visit to the diagnosis 
of sarcoidosis was 7.5 months; and the median 
time elapsed from the onset of symptoms or 
from an abnormal radiological finding to the 
diagnosis of sarcoidosis was 12 months. Fifty-
three patients consulted with a physician within 
1 month after the onset of symptoms, and 82 
Variable Result
Symptoms
Absent 13
Systemic 59
Fever 20
Weight loss 46
Night sweats 35
Pulmonary 70
Extrathoracic adenopathy 23
Skin lesions 30
Ocular disease 12
Baseline dyspnea indexc
> 6 79
≤ 6 19
Spirometryb
FVC, % of predicted 84.5 ± 19.7
FEV1, % of predicted 81.1 ± 19.9
FEV1/FVC 0.79 ± 0.10
Radiological staging
0/I/II/III/IV 8/21/35/29/7
Biopsy site/typed
Transbronchial biopsy 49
Skin 17
Extrathoracic adenopathy 16
Surgical lung biopsy 11
Mediastinoscopy 8
Testicle 1
Table 2 - Clinical, functional, and radiological findings, 
as well as biopsy sites showing granulomas, in 100 
patients with sarcoidosis.a
aValues expressed as n of patients, except where otherwise 
indicated. bValues expressed as mean ± SD. cn = 98. dA total 
of 102 biopsies were performed in 100 patients.
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The present study was inspired by another 
study,(7) which showed that the time elapsed 
from the onset of symptoms to diagnosis, as 
well as the time elapsed from the first medical 
visit to diagnosis, was longer in patients with 
pulmonary symptoms; the presence of skin 
involvement was associated with a shorter time 
to diagnosis of sarcoidosis. In the present study, 
the abovementioned findings had no influence 
on the time to diagnosis. 
The time to diagnosis of sarcoidosis (from 
the onset of symptoms and from the first 
medical visit) was not affected by gender, race, 
individual income, or type of health insurance. 
According to the Brazilian Institute of Geography 
and Statistics,(13) the mean monthly individual 
income in São Paulo at the time of the study 
was approximately 850 Brazilian reals, which is 
similar to the mean value found in the present 
study (approximately 800 Brazilian reals). 
In most cases, a general practitioner was the 
first physician consulted. However, the diagnosis 
of sarcoidosis was made at the first visit in only 
1 case. Pulmonologists were the first physicians 
consulted in 13 cases, and the diagnosis of 
sarcoidosis was made in only 3 of those cases. 
Seventeen patients were diagnosed with 
tuberculosis, none of whom had bacteriological 
confirmation. All 17 initially received treatment 
for tuberculosis, 12 of whom received it for 3 
months or more. As expected, those who were 
treated for 3 months or more had a delayed 
diagnosis (Table 3). Ten patients were diagnosed 
as having tuberculosis by pulmonologists, 4 were 
diagnosed as having tuberculosis by general 
practitioners, and 3 were diagnosed as having 
tuberculosis by other professionals. Of the 17 
patients who were diagnosed with tuberculosis, 
15 (88.2%) had systemic symptoms, compared 
with 44 (53.0%) of the 83 patients not having 
been so diagnosed (χ2 = 7.24; p = 0.007). 
Discussion
The present study confirms that delayed 
diagnosis of sarcoidosis is common. The diagnosis 
of sarcoidosis was delayed by 6 months or more 
in approximately 60% of the cases. Only 11% of 
the patients were diagnosed by the first physician 
consulted. In 26% of the cases, five or more 
physicians were consulted before the correct 
diagnosis of sarcoidosis. 
Variable Timely diagnosis Delayed diagnosis p
(n = 41) (n = 59)
Age, yearsb 44.9 ± 10.7 49.4 ± 12.7 0.069
Symptoms
Absent 4 (9.8) 9 (16.9) 0.421
Systemic 24 (58.5) 35 (59.3) 0.937
Pulmonary 26 (63.4) 44 (74.6) 0.231
Extrathoracic adenopathy 11 (26.8) 12 (20.3) 0.575
Skin lesions 9 (22.0) 21 (35.6) 0.143
Ocular disease 3 (7.3) 9 (15.2) 0.230
Baseline dyspnea indexc 6 (14.3) 13 (22.6) 0.303
≤ 6 8 (18.2) 14 (22.0) 0.833
Spirometryb
FVC, % of predicted 90.5 ± 17.1 80.3 ± 20.4 0.010
FEV1, % of predicted 86.4 ± 19.5 77.3 ± 19.9 0.024
FEV1/FVC 0.79 ± 0.11 0.79 ± 0.10 0.981
Radiological staging
0/I/II/III/IV 2/11/17/10/1 6/10/18/19/6 0.251
HRCT staging (n = 39) (n = 58)
0/I/II/III/IV 0/8/19/3/9 1/9/22/7/19 0.585
Diagnosis of tuberculosis 3 (7.3) 14 (23.7) 0.032
Treatment of tuberculosis for ≥ 3 months 0 (0) 12 (20.3) < 0.002
Table 3 - Clinical, functional, and radiological findings in 100 patients with sarcoidosis, by time to 
diagnosis—timely (< 6 months) or delayed (≥ 6 months).a
aValues expressed as n (%), except where otherwise indicated. bValues expressed as mean ± SD. cn = 98.
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Two biases in the present study merit 
consideration. One is a recruitment bias; it is 
possible that the sarcoidosis patients included 
in the present study are not representative of 
sarcoidosis patients in general. Regarding age 
and gender, our findings are similar to those 
of two epidemiological studies, one in Holland 
and the other in Japan.(14,15) A study conducted 
in the United States, designated A Case Control 
Etiologic Study of Sarcoidosis,(16) involved a large, 
representative sample of patients with sarcoidosis. 
The results of that study showed similarities 
and differences in comparison with those of 
the present study. As occurred in our study, 
the mean age was higher for females, and the 
proportions of skin involvement, extrathoracic 
lymph nodes, and ocular involvement were 
very similar between the two studies. However, 
the proportion of patients with stage III/IV 
sarcoidosis was higher in our sample (36% 
vs. 16%), whereas that of those with stage I 
sarcoidosis was lower (21% vs. 40%).(16) 
In Brazil, there have been no population-based 
studies investigating sarcoidosis. Two studies 
conducted at referral centers in two different cities 
(Porto Alegre and Rio de Janeiro) showed overall 
findings in patients with sarcoidosis.(17,18) Both 
studies showed that the disease is more common 
in female patients, most patients having stage 
II or III sarcoidosis. In one of those studies,(18) 
6 of 100 sarcoidosis patients had initially been 
diagnosed with tuberculosis. The time to diagnosis 
was not reported in those studies. Therefore, 
the present study is similar to other Brazilian 
studies conducted at referral centers. However, 
the patients with sarcoidosis investigated in 
those studies are probably not representative 
of those in the general population. It is possible 
that patients with earlier stage disease were not 
referred to those centers. However, in the present 
study, the number of patients with stage I or 
II sarcoidosis (n = 28) was the same in both 
groups (with and without delayed diagnosis). 
Therefore, the fact that the number of patients 
with stage I or II sarcoidosis was lower in our 
study than in population-based studies does 
not explain the findings. 
Another potential bias in our study is a recall 
bias due to the fact that, in many cases, the 
questionnaires were administered retrospectively. 
We tried to minimize that by excluding patients 
who were unable to recall the details of their 
cases. However, this is a subjective task, and we 
did not record the number of patients excluded 
on the basis of that criterion. 
In those patients in whom the time elapsed 
from the onset of symptoms to diagnosis was 
longer, FVC was lower. This finding suggests that 
a delayed diagnosis of pulmonary sarcoidosis 
results in worsening of lung dysfunction in the 
absence of treatment. Unfortunately, we did not 
record long-term changes in pulmonary function 
tests after treatment. 
In the present study, we found no relationship 
between radiological staging and delayed diagnosis. 
Although HRCT is superior to chest X-ray for 
detecting nodules and mediastinal lymph node 
enlargement,(19) these findings were not useful 
for earlier diagnosis. In the absence of pathologic 
confirmation, clinical and radiological findings can 
be useful for the diagnosis of stage I sarcoidosis 
(reliability, 98%) and stage II sarcoidosis (reliability, 
89%), being, however, less accurate for the 
diagnosis of stage III sarcoidosis (reliability, 
52%) and stage 0 sarcoidosis (reliability, 23%).
(1,3) Asymptomatic bilateral hilar lymphadenopathy 
without systemic findings or with acute symptoms 
(uveitis, polyarthritis, or erythema nodosum) is 
highly suggestive of sarcoidosis,(4,20) histological 
confirmation being therefore unnecessary. A 
combination of pulmonary nodules with hilar/
mediastinal adenopathy should immediately raise 
the suspicion of sarcoidosis. In this context, 
nodules with a lymphatic distribution on HRCT 
scans constitute further evidence for a diagnosis 
of sarcoidosis. In a retrospective review of 91 cases 
of patients with hilar adenopathy and pulmonary 
nodules in our registry of interstitial lung disease 
cases, sarcoidosis was diagnosed in 76 (84%), 
silicosis was diagnosed in 10 (11%), and other 
diseases were diagnosed in 5 (5%; unpublished 
data). In the present study, this combination 
was not useful for earlier diagnosis. 
A total of 17 patients were misdiagnosed as 
having tuberculosis. Of those, 12 were treated 
for more than 3 months and 4 completed the 
standard 6-month treatment established in Brazil. 
This shorter treatment duration probably reflects 
a reconsideration of the diagnosis after a lack 
of response to tuberculosis treatment. 
During the study period, in the three facilities 
involved, only 1 patient initially treated as 
having sarcoidosis was later confirmed as having 
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of patients in a case control study of sarcoidosis. Am 
J Respir Crit Care Med. 2001;164(10 Pt 1):1885-9. 
http://dx.doi.org/10.1164/ajrccm.164.10.2104046 
PMid:11734441
17. Silva LC, Hertz FT, Cruz DB, Caraver F, Fernandes JC, 
Fortuna FP, et al. Sarcoidosis in the south of Brazil: a 
study of 92 patients. J Bras Pneumol. 2005;31(5):398-406. 
http://dx.doi.org/10.1590/S1806-37132005000500007
18. Lemos-Silva V, Araújo PB, Lopes C, Rufino R, da Costa 
CH. Epidemiological characteristics of sarcoidosis patients 
in the city of Rio de Janeiro, Brazil. J Bras Pneumol. 
2011;37(4):438-45. http://dx.doi.org/10.1590/S1806-
37132011000400005 PMid:21881733
tuberculosis. The patient in question was excluded 
from the present study. 
In patients with sarcoidosis, the only finding 
associated with more frequent diagnosis of 
tuberculosis was the presence of systemic symptoms. 
Weight loss, fever, and night sweats are common 
findings in patients with sarcoidosis.(6) Fatigue, 
which is another common finding in patients with 
sarcoidosis,(21) was not evaluated in the present study. 
The risks of treating sarcoidosis as tuberculosis 
are not negligible.(22) In addition, potentially 
serious forms of sarcoidosis, such as cardiac 
sarcoidosis, can go undetected because of the 
lack of systematic investigation. Ten of the 17 
patients treated as having tuberculosis had bilateral 
hilar lymphadenopathy, which is a rare finding in 
patients with tuberculosis and should therefore 
suggest the correct diagnosis. 
One study evaluated the usefulness of 
PCR in biopsy specimens in differentiating 
between patients with sarcoidosis and those 
with tuberculosis.(23) In all 31 cases of patients 
with tuberculosis, PCR was positive, as it was 
in 20 of 104 cases of patients with sarcoidosis. 
A quantitative analysis was able to distinguish 
between the two groups. However, these findings 
should be confirmed at other centers. 
In conclusion, the diagnosis of sarcoidosis 
is delayed in many cases, even when there are 
imaging findings suggestive of sarcoidosis. Delayed 
diagnosis is associated with lower lung function at 
diagnosis. In some cases, patients are diagnosed 
with and treated for tuberculosis. This delays the 
correct diagnosis. General practitioners and even 
pulmonologists should become more familiar with 
the findings that are suggestive of sarcoidosis. 
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